The role of hyperlipidemia as a risk factor for stroke is unclear. A new retrospective study has examined the relationship between a history of hyperlipidemia and MRI-defined white matter hyperintensities in patients with acute ischemic stroke. The results indicate that hyperlipidemia might have a protective role against cerebral small-vessel disease.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Chronic gastritis may predict risk of cerebral small vessel disease
BMC Gastroenterology Open Access 07 December 2023
-
Role of Cognitive Enhancer Therapy in Alzheimer’s Disease with Concomitant Cerebral White Matter Disease: Findings from a Long-Term Naturalistic Study
Drugs in R&D Open Access 26 July 2014
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Jeerakathil, T. et al. Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study. Stroke 35, 1857–1861 (2004).
Jimenez-Conde, J. et al. Hyperlipidemia and reduced white matter hyperintensity volume in patients with ischemic stroke. Stroke 41, 437–442 (2010).
Longstreth, W. T. Jr et al. Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. Stroke 36, 56–61 (2005).
Leys, D. et al. White matter changes in stroke patients. Relationship with stroke subtype and outcome. Eur. Neurol. 42, 67–75 (1999).
Laloux, P., Galanti, L. & Jamart, J. Lipids in ischemic stroke subtypes. Acta Neurol. Belg. 104, 13–19 (2004).
Bejot, Y. et al. Ischaemic stroke subtypes and associated risk factors: a French population based study. J. Neurol. Neurosurg. Psychiatry 79, 1344–1348 (2008).
Olsen, T. S., Christensen, R. H., Kammersgaard, L. P. & Andersen, K. K. Higher total serum cholesterol levels are associated with less severe strokes and lower all-cause mortality: ten-year follow-up of ischemic strokes in the Copenhagen Stroke Study. Stroke 38, 2646–2651 (2007).
Mega, J. L., Morrow, D. A., Brown, A., Cannon, C. P. & Sabatine, M. S. Identification of genetic variants associated with response to statin therapy. Arterioscler. Thromb. Vasc. Biol. 29, 1310–1315 (2009).
Lemmens, R., Görner, A., Schrooten, M. & Thijs, V. Association of apolipoprotein E ɛ2 with white matter disease but not with microbleeds. Stroke 38, 1185–1188 (2007).
White, H. et al. Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation 111, 1327–1331 (2005).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Warsch, J., Wright, C. Hyperlipidemia and cerebral small-vessel disease. Nat Rev Neurol 6, 307–308 (2010). https://doi.org/10.1038/nrneurol.2010.70
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2010.70
This article is cited by
-
Chronic gastritis may predict risk of cerebral small vessel disease
BMC Gastroenterology (2023)
-
Effects of sartans and low-dose statins on cerebral white matter hyperintensities and cognitive function in older patients with hypertension: a randomized, double-blind and placebo-controlled clinical trial
Hypertension Research (2019)
-
Role of Cognitive Enhancer Therapy in Alzheimer’s Disease with Concomitant Cerebral White Matter Disease: Findings from a Long-Term Naturalistic Study
Drugs in R&D (2014)
-
Hurdles to Clear Before Clinical Translation of Ischemic Postconditioning Against Stroke
Translational Stroke Research (2013)
